Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × High-Energy Shock Waves × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Anatomic Stage III Breast Cancer AJCC v8 2 Anatomic Stage I Breast Cancer AJCC v8 2 Uterine Cervical Neoplasms 1 Thyroid Cancer, Papillary 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Renal Insufficiency, Chronic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Ganglioneuroblastoma 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 16 Nivolumab 12 avelumab 8 Ipilimumab 6 Specimen Handling 5 Biopsy 5 atezolizumab 4 Magnetic Resonance Spectroscopy 4 cemiplimab 3 Cyclophosphamide 3 poly ICLC 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Radiotherapy 2 Radiosurgery 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 flt3 ligand protein 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡